Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Moreau

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Journal of Clinical Bioinformatics|August 8, 2012
A model-based statistic for detecting molecular markers associated with complex survival patterns in early-stage cancerPhilippe Broët, Thierry Moreau
Biochimie|May 18, 2010
Phage display as a powerful tool to engineer protease inhibitorsMarie-Louise Zani, Thierry Moreau
Bioinformatics (Oxford, England)|October 14, 2004
A simple procedure for estimating the false discovery rateCyril Dalmasso, Philippe Broët, Thierry Moreau
Biochimie|November 21, 2007
Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functionsBrice Korkmaz, Thierry Moreau, Francis Gauthier
BMC Bioinformatics|March 26, 2010
Identifying common prognostic factors in genomic cancer studies: a novel index for censored outcomesSigrid Rouam, Thierry Moreau, Philippe Broët
Breast Cancer Research and Treatment|June 12, 2008
Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-pointsBilal Majed, Thierry Moreau, Bernard Asselain, et al.
BMC Medical Research Methodology|March 16, 2011
A pseudo-R2 measure for selecting genomic markers with crossing hazards functionsSigrid Rouam, Thierry Moreau, Philippe Broët
Therapie|July 10, 2016
[Not Available]Thierry Moreau Defarges, Michel Guerbet, Jacques Massol, et al.
Therapie|August 20, 2011
Impact of drugs on the environment: state of play, risks, evaluation, communicationThierry Moreau Defarges, Michel Guerbet, Jacques Massol, et al.
Lifetime Data Analysis|August 6, 2004
Two-sample statistics for testing the equality of survival functions against improper semi-parametric accelerated failure time alternatives: an application to the analysis of a breast cancer clinical trialPhilippe Broët, Alexander Tsodikov, Yann De Rycke, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Journal of Clinical Bioinformatics|August 8, 2012
A model-based statistic for detecting molecular markers associated with complex survival patterns in early-stage cancerPhilippe Broët, Thierry Moreau
Biochimie|May 18, 2010
Phage display as a powerful tool to engineer protease inhibitorsMarie-Louise Zani, Thierry Moreau
Bioinformatics (Oxford, England)|October 14, 2004
A simple procedure for estimating the false discovery rateCyril Dalmasso, Philippe Broët, Thierry Moreau
Biochimie|November 21, 2007
Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functionsBrice Korkmaz, Thierry Moreau, Francis Gauthier
BMC Bioinformatics|March 26, 2010
Identifying common prognostic factors in genomic cancer studies: a novel index for censored outcomesSigrid Rouam, Thierry Moreau, Philippe Broët
Breast Cancer Research and Treatment|June 12, 2008
Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-pointsBilal Majed, Thierry Moreau, Bernard Asselain, et al.
BMC Medical Research Methodology|March 16, 2011
A pseudo-R2 measure for selecting genomic markers with crossing hazards functionsSigrid Rouam, Thierry Moreau, Philippe Broët
Therapie|July 10, 2016
[Not Available]Thierry Moreau Defarges, Michel Guerbet, Jacques Massol, et al.
Therapie|August 20, 2011
Impact of drugs on the environment: state of play, risks, evaluation, communicationThierry Moreau Defarges, Michel Guerbet, Jacques Massol, et al.
Lifetime Data Analysis|August 6, 2004
Two-sample statistics for testing the equality of survival functions against improper semi-parametric accelerated failure time alternatives: an application to the analysis of a breast cancer clinical trialPhilippe Broët, Alexander Tsodikov, Yann De Rycke, et al.
Pageof 7